Bruker Introduces Innovative Fourier 80 Multinuclear Benchtop FT-NMR

Unique Fourier 80 ‘Multi-Talent’ offers1H NMR and choice of 15 X-nuclei with just one click ASILOMAR, Calif. -- At the Joint ENC-ISMAR Conference 2025, Bruker Corporation, the leading provider of Nuclear Magnetic Resonance (NMR) spectroscopy solutions, announced the launch of an innovative Fourier 80 multinuclear benchtop FT-NMR spectrometer, known as the ‘Multi-Talent’ configuration. This novel Fourier [...]

Valted Seq Launches Revolutionary AI-Powered Genomics Tool to Accelerate Breakthroughs in Healthcare and Life Sciences

AI-powered genomics tool, SCADE, significantly outperforms by more than doubling the accuracy of generic models, including those from OpenAI and DeepSeek, in solving single-cell genomics problems GAITHERSBURG, Md. -- Valted Seq, Inc., a pioneer in cutting-edge biotechnology solutions, today announced the launch of a novel AI-powered genomics tool, Single Cell AI Discovery Engine (SCADE), designed [...]

Surplus Solutions, an NMS Capital Portfolio Company, Expands Capabilities in Refurbished Laboratory Equipment and Technical Services; Announces Partnership with Certified Genetool

NEW YORK and WOONSOCKET, R.I. -- Surplus Solutions LLC (“Surplus Solutions”), a portfolio company of NMS Capital (“NMS”), announced today the acquisition of Certified Genetool (or the “Company”), a San Francisco-based provider of certified laboratory instruments and technical services. The acquisition expands Surplus Solutions’ operational capabilities and supports continued growth in the biotechnology, pharmaceutical, and [...]

AGC Biologics Strengthens Single-Use Technology Network, Adds 5,000 L Vessels from Thermo Scientific to New Yokohama, Japan Facility

New CDMO site introducing the most advanced and large-scale single-use bioreactors in Japan Today, we announced a strategic decision about the large-scale single-use technology it will use at its new Yokohama, Japan facility. The CDMO is introducing two 5,000 L Thermo Scientific DynaDrive Single-Use Bioreactors (S.U.B.), which makes the site one of the most advanced [...]

BICO has entered into an agreement to divest MatTek to Sartorius for USD 80m

BICO Group AB (“BICO”) has entered into an agreement to divest MatTek Corp (“MatTek”) and Visikol Inc (“Visikol”) to Sartorius Lab Holding GmbH (“Sartorius”) for USD 80m, on a cash and debt-free basis. The divestment follows the Group’s updated strategy with focus on lab automation and selected workflows. The proceeds from the transaction will be [...]

Sartorius to acquire microtissue business MatTek from Swedish BICO AB

Acquisition will advance Sartorius’ cell culture portfolio with 3D microtissue models and primary cells MatTek’s solutions are highly compatible with Sartorius’ cell analysis instruments, reagents and AI models for faster and more effective drug development Göttingen, Germany -- The life science group Sartorius has agreed to acquire MatTek Corp, including Visikol Inc, from BICO Group [...]

Biolyst Scientific Appoints Jay Hexamer as Chief Executive Officer to Lead Next Phase of Growth

HATFIELD, Pa. -- Biolyst Scientific, a leading provider of innovative solutions in the life sciences and clinical laboratory markets, is pleased to announce the appointment of Jay Hexamer as its new Chief Executive Officer (CEO), effective immediately. This leadership transition reflects Biolyst Scientific's continued focus on innovation and market expansion. With more than 30 years of experience in [...]

UniteLabs secures €2.77M to build the operating system for AI-driven biotech research

Munich-based lab automation startup raised €2.77M in a pre-seed funding round led by NAP (formerly Cavalry Ventures) with PUSH, Acurio Ventures, OMA Business Angels, and LANA Ventures also participating. Fundraising Announcement Munich – UniteLabs, a startup specializing in lab automation for biotechnology, has raised €2.77 million in a pre-seed funding round led by NAP (formerly Cavalry Ventures). [...]

Vizgen Announces End of Litigation with 10x Genomics and Harvard University

Settlement Supports Vizgen’s Continued Commercialization and Ongoing Development of Transformative MERFISH Technology CAMBRIDGE, Mass. -- Vizgen, Inc., the life sciences company revolutionizing spatial genomics research and driving innovation in spatial multi-omics, today released an open letter in response to the settlement of litigation between Vizgen, Harvard University and 10X Genomics in the United States District [...]

Tecan expands portfolio for specialty diagnostics with an asset purchase relating to certain ELISA kits

Männedorf, Switzerland – Tecan Group (SIX Swiss Exchange: TECN) today announced an agreement to acquire certain assets relating to key ELISA immunoassay products from Cisbio Bioassays SAS, a subsidiary of the global life sciences and diagnostics company, Revvity Inc. The asset purchase includes the manufacturing process of four ELISA kits – two in vitro diagnostic (IVD) products for specialty [...]

Access IBO on Knowledge Center